During the past decade, MVZ für Rheumatologie Dr. Martin Welcker GmbH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "MVZ für Rheumatologie Dr. Martin Welcker GmbH" #1 collaborator was "Amgen" with 1 trials as a collaborator and "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "MVZ für Rheumatologie Dr. Martin Welcker GmbH" are "Psoriatic Arthritis" (2 trials), "Ankylosing Spondylitis" (1 trials), "Rheumatoid Arthritis" (1 trials) and "Rheumatoid Diseases" (1 trials). Many other conditions were trialed in "MVZ für Rheumatologie Dr. Martin Welcker GmbH" in a lesser frequency.

Most popular intervention types in "MVZ für Rheumatologie Dr. Martin Welcker GmbH" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CT-P13" (1 trials) and "Questionnaire" (1 trials). Other intervention names were less common.

The vast majority of trials in "MVZ für Rheumatologie Dr. Martin Welcker GmbH" are 2 trials for "All" genders.

Currently, there are NaN active trials in "MVZ für Rheumatologie Dr. Martin Welcker GmbH". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in MVZ für Rheumatologie Dr. Martin Welcker GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MVZ für Rheumatologie Dr. Martin Welcker GmbH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".